GRL-0617

GRL-0617是一种药物，是最早被发现可作为木瓜蛋白酶样蛋白酶的选择性小分子抑制剂的化合物之一，它可在某些致病病毒（包括冠状病毒SARS-CoV-2）中发现。它已被证明可以在体外抑制病毒复制。^[1][2][3][4]

GRL-0617

识别信息
IUPAC命名法 5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide
CAS号	1093070-16-6
PubChem CID	24941262
IUPHAR/BPS	11078
DrugBank	DB08656
ChemSpider	24617535
UNII	GRL-0617
ChEBI	CHEBI:167176
ChEMBL	ChEMBL549695
化学信息
化学式	C20H20N2O
摩尔质量	304.39 g·mol^−1
3D模型（JSmol（英语：JSmol））	交互式图像
SMILES CC1=C(C=C(C=C1)N)C(=O)N[C@H](C)C2=CC=CC3=CC=CC=C32
InChI InChI=1S/C20H20N2O/c1-13-10-11-16(21)12-19(13)20(23)22-14(2)17-9-5-7-15-6-3-4-8-18(15)17/h3-12,14H,21H2,1-2H3,(H,22,23)/t14-/m1/s1 Key:UVERBUNNCOKGNZ-CQSZACIVSA-N

参见

• 3CLpro-1
• 依布硒
• GC376

参考文献

1. Shin D, Mukherjee R, Grewe D, Bojkova D, Baek K, Bhattacharya A, et al. Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature. November 2020, 587 (7835): 657–662. Bibcode:2020Natur.587..657S. PMC 7116779  . PMID 32726803. doi:10.1038/s41586-020-2601-5. 
2. Hajbabaie R, Harper MT, Rahman T. Establishing an Analogue Based In Silico Pipeline in the Pursuit of Novel Inhibitory Scaffolds against the SARS Coronavirus 2 Papain-Like Protease (PDF). Molecules. February 2021, 26 (4): 1134 [2022-12-12]. PMC 7924369  . PMID 33672721. doi:10.3390/molecules26041134  . （原始内容 (PDF)于2022-12-12）. 
3. Lim CT, Tan KW, Wu M, Ulferts R, Armstrong LA, Ozono E, et al. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of Nsp3 papain-like protease. The Biochemical Journal. July 2021, 478 (13): 2517–2531. PMC 8286840  . PMID 34198325. doi:10.1042/BCJ20210244. 
4. Xiang R, Yu Z, Wang Y, Wang L, Huo S, Li Y, et al. Recent advances in developing small-molecule inhibitors against SARS-CoV-2. Acta Pharmaceutica Sinica. B. July 2021. PMC 8260826  . PMID 34249607. doi:10.1016/j.apsb.2021.06.016.